Who invested in Brainomix

5 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$52Mraised across 5 rounds since 2014, from 5 sources

$2.0MSeries A$9.8MRound$22MSeries B$237KSeries B$18MSeries C

Latest round: Series C, $18MMar 2025
Biggest round: $22MSeries B · Dec 2021
Step-upi: 76.8×
Investors: 9

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20162018202020222024

$2.0MSeries A$9.8MRound$22MSeries B$237KSeries B$18MSeries C

First round: Series A, $2.0M
Biggest round: $22M
Usual gap between rounds: 3.5 years

The rounds

Mar 2025
Series C$18M4 new1 returning
Source recorded
Jun 2022
Series B$237K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Dec 2021
Series B$22M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Apr 2018
Round$9.8M3 new
- Boehringer Ingelheim
- Oxford University Innovation
- Parkwalk Advisors/ Chimera
Reported by FinSMEs
Sept 2014
Series A$2.0M2 new
- Parkwalk
- Chimera Partners
From a historical funding record

Funding filed with regulators

Brainomix filed 3 raises, $39M in all. Filings say how much was sold and to how many investors; they never name the investors.

Jan 2025$17MUK share allotment
Jun 2022$237KUK share allotment
Dec 2021$22MUK share allotment

Founders and team

From Brainomix's own website: 1 founder, 10 on the team.

Dr Michalis PapadakisCEO & Co-Founder

Anna GriffinChief Financial Officer
Dr George HarstonChief Medical & Innovation Officer
Eric GrevesonChief Technology Officer
Jeff WyrtzenChief Marketing Officer
Jérôme Galbrun PhDChief Revenue Officer
David BallParkwalk Director
Dr Davide CaroneSenior Medical Director
Dr James BriggsSenior Medical Director, Product & Medical Affairs
Dr Oliver ReussBoehringer Ingelheim Venture Fund Director
Khush MehtaChair

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2014Round2018Series B2021Series B2022Series C2025

Parkwalk

Innovate UK

Tengxun Touzi

EASME - EU Executive Agency for SMEsBoehringer Ingelheim Venture FundBoehringer IngelheimChimera Partners

Oxford University InnovationParkwalk Advisors/ Chimera

Everyone who backed them

ParkwalkVC firm2rounds

Innovate UKVC firm1round

Tengxun TouziVC firm1round

EASME - EU Executive Agency for SMEsGovernment1round

Boehringer Ingelheim Venture FundCorporate VC1round

Boehringer IngelheimVC firm1round

Chimera PartnersVC firm1round

Oxford University InnovationAdvisor1round

Parkwalk Advisors/ Chimerano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Brainomix

Who invested in Brainomix?

Brainomix's investors include Parkwalk, Innovate UK, Tengxun Touzi, EASME - EU Executive Agency for SMEs and Boehringer Ingelheim Venture Fund, and 4 more on record.